Ischemic Stroke News and Research

RSS

1 in 3 people in the US could not access a stroke centre within an hour

A new study published today reports that a large proportion of the United States would be unable to access primary a stroke centre within one hour by ambulance. Stroke is a leading cause of death and disability and rapid treatment is essential to minimise damage to the brain and reduce the risk of prolonged disability.

6 Mar 2015

NeuroPerspective features comprehensive reviews of schizophrenia, spinal cord injury

NI Research has released the March/April issue of NeuroPerspective, which features comprehensive reviews of two major areas: Schizophrenia and Spinal cord injury.

3 Mar 2015

Neuroprotective compounds can limit damage to the brain during ischemic stroke

In the 1990s, neuroscientists identified a class of drugs that showed promise in the area of stroke. NMDA receptor antagonists could limit damage to the brain in animal models of stroke. But one problem complicated testing the drugs in a clinical setting: the side effects included disorientation and hallucinations.

28 Feb 2015

People who exhibit resistance to aspirin may be at risk of more severe strokes

People who exhibit a resistance to aspirin may be more likely to have more severe strokes than people who still respond to the drug, according to a study released today that will be presented at the American Academy of Neurology's 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.

24 Feb 2015

Discoveries by WA research team offer further treatment hope for victims of stroke

A West Australian research team has made a series of discoveries which may help to minimise the damage that a stroke can cause.

20 Feb 2015

Simulation-based medical education teaches neurology residents how to treat stroke patients

One of the most challenging cases that a first-year neurology resident physician can face is a stroke patient in the emergency department.

16 Feb 2015

Landmark stroke studies presented at ISC, published in NEJM suggest new treatment protocol on the horizon

Research presented today at the International Stroke Conference (ISC) in Nashville, Tenn. and published online in The New England Journal of Medicine (NEJM) found that the addition of the Solitaire™ Device stent thrombectomy procedure to current pharmaceutical treatment significantly reduced disability in patients suffering stroke.

From Medtronic 13 Feb 2015

Clinical trial proves ‘inside the artery’ therapy improves patient outcomes after stroke

"This clinical trial proves beyond any doubt that inside the artery therapy is the best possible treatment for patients suffering an acute ischemic stroke from a large artery occlusion," according to Donald Frei, MD, Neuro Interventional Surgeon at Swedish Medical Center and Radiology Imaging Associates in Englewood, CO.

13 Feb 2015

Retigabine drug shows promise in protecting the brain against effects of ischemic stroke

Retigabine, a drug approved to treat epilepsy, protected the brain against the effects of ischemic stroke in a study conducted at The University of Texas Health Science Center at San Antonio.

12 Feb 2015

Endovascular treatment can improve patient outcomes after acute ischemic stroke

Canadian researchers have completed an international randomized controlled trial showing that a clot retrieval procedure, known as endovascular treatment (ET), can dramatically improve patient outcomes after an acute ischemic stroke. The study, led by researchers at the University of Calgary's Hotchkiss Brain Institute (HBI), shows a dramatic improvement in outcomes and a reduction in deaths from stroke.

12 Feb 2015

Landmark study heralds new era in stroke treatment worldwide

A landmark study published in the New England Journal of Medicine today heralds a new era in stroke treatment across the globe.

12 Feb 2015

Studies show neurointerventional surgery reduces stroke mortality rate by 50%

Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities.

12 Feb 2015

Retigabine drug could reduce debilitating impact of strokes

New research suggests that an already-approved drug could dramatically reduce the debilitating impact of strokes, which affect nearly a million Americans every year.

5 Feb 2015

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair of Retinal Degeneration Research, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered gene interactions that determine whether cells live or die in such conditions as age-related macular degeneration and ischemic stroke.

31 Jan 2015

Study finds no evidence that testosterone replacement therapy increases cardiovascular risk

Fears of a link between testosterone replacement therapy and cardiovascular risk are misplaced, according to a review published in this month's Mayo Clinic Proceedings. The therapy has come under widespread scrutiny in recent months, including by a federal Food and Drug Administration panel convened last fall.

28 Jan 2015

Male stroke patients who live alone are at greater risk of premature death

Men who live alone have a considerably greater long-term risk of dying prematurely than other patients. This is shown in a doctoral thesis that followed 1,090 stroke cases in western Sweden.

21 Jan 2015

Daiichi Sankyo receives FDA approval for SAVAYSA (edoxaban) Tablets

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).

8 Jan 2015

Ischemic Stroke News and Research

1 in 3 people in the US could not access a stroke centre within an hour

NeuroPerspective features comprehensive reviews of schizophrenia, spinal cord injury

Neuroprotective compounds can limit damage to the brain during ischemic stroke

People who exhibit resistance to aspirin may be at risk of more severe strokes

Discoveries by WA research team offer further treatment hope for victims of stroke

Simulation-based medical education teaches neurology residents how to treat stroke patients

Landmark stroke studies presented at ISC, published in NEJM suggest new treatment protocol on the horizon

Clinical trial proves ‘inside the artery’ therapy improves patient outcomes after stroke

Retigabine drug shows promise in protecting the brain against effects of ischemic stroke

Endovascular treatment can improve patient outcomes after acute ischemic stroke

Landmark study heralds new era in stroke treatment worldwide

Studies show neurointerventional surgery reduces stroke mortality rate by 50%

Retigabine drug could reduce debilitating impact of strokes

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Study finds no evidence that testosterone replacement therapy increases cardiovascular risk

Male stroke patients who live alone are at greater risk of premature death

Daiichi Sankyo receives FDA approval for SAVAYSA (edoxaban) Tablets

Study: Placental cells may possibly treat damaged nerves

Novastem uses Stemedica's stem cell products to treat patient in ischemic stroke study

Treatment for stroke: Intra-arterial treatment more effective than standard medical care for clot removal

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News